Metabolic Characteristics of Type 2 Diabetes Mellitus Combined With Acute Myocardial Infarction: A Untargeted Metabolomics Study

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

May 23, 2017

Primary Completion Date

May 28, 2020

Study Completion Date

May 28, 2020

Conditions
STEMI
Interventions
DEVICE

liquid chromatography-mass spectrometry (LC/MS) analysis

To obtain a complete metabolic profile, untargeted metabolomics analysis was conducted by using UPLC-MS. Chromatographic separation was accomplished in an Thermo Vanquish system equipped with an ACQUITY UPLC®HSS T3 (150×2.1 mm, 1.8 µm, Waters, USA) column maintained at 40 ℃. The temperature of the autosampler was 8 ℃. The ESI-MSn experiments were executed on the Thermo Q Exactive mass spectrometer with the spray voltage of 3.5 kV and -2.5 kV in positive and negative modes, respectively. The capillary temperature was 325℃. The analyzer scanned over a mass range of m/z 81-1 000 for full scan at a mass resolution of 70 000. The normalized collision energy was 30 eV(19606840). The detected ions were all under isotopic calibration with the accurate masses of the reference standards.

Trial Locations (1)

100032

Weiping Li, Beijing

All Listed Sponsors
lead

Beijing Friendship Hospital

OTHER

NCT05601310 - Metabolic Characteristics of Type 2 Diabetes Mellitus Combined With Acute Myocardial Infarction: A Untargeted Metabolomics Study | Biotech Hunter | Biotech Hunter